triple hormone receptor agonist retatrutide is a triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing A phase 2 clinical trial
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14






![Official Store🇺🇸] Lmipki® NIDDK-Tirzepatide Nano Microneedle Patch](https://lmipki.net/wp-content/uploads/2025/06/Official-Store-Lmipki-NIDDK-Tirzepatide-Nano-Microneedle-Patch-1072-1-247x296.webp)








![Lmipki® Official Store】💡[See results in 7 days]✓NIDDK-Tirzepatide Nano Microneedle Patch](https://lmipki.net/wp-content/uploads/2025/06/Lmipki-Official-StoreSee-results-in-7-daysNIDDK-Tirzepatide-Nano-Microneedle-Patch-1047-4.webp)











